EPSTEIN BARR VIRUS
Clinical trials for EPSTEIN BARR VIRUS explained in plain language.
Never miss a new study
Get alerted when new EPSTEIN BARR VIRUS trials appear
Sign up with your email to follow new studies for EPSTEIN BARR VIRUS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Moderna launches first human trial of EBV mRNA vaccine
⭐️ VACCINE ⭐️ Recruiting nowThis early-stage study is testing an experimental mRNA vaccine called mRNA-1189 to see if it is safe and can trigger an immune response against Epstein-Barr virus (EBV). The trial involves 120 healthy adults aged 18 to 30. Researchers will compare two ways of giving the vaccine: …
Matched conditions: EPSTEIN BARR VIRUS
Phase: PHASE1 • Sponsor: ModernaTX, Inc. • Aim: ⭐️ VACCINE ⭐️
Last updated May 01, 2026 16:00 UTC
-
Massive health survey aims to uncover hidden disease hotspots in cambodia
Knowledge-focused Recruiting nowThis study will test 10,000 people in Cambodia for antibodies against 57 different infectious diseases, including dengue, flu, and malaria. The goal is to learn which diseases are common, how they spread between people and animals, and who is most at risk. Results will help local…
Matched conditions: EPSTEIN BARR VIRUS
Sponsor: Institut Pasteur du Cambodge • Aim: Knowledge-focused
Last updated May 04, 2026 16:24 UTC